Skip to content
Clinical Trials – home
Universitaetsklinikum Essen AöR
Sponsor

Universitaetsklinikum Essen AöR

Germany Hufelandstrasse 55, Holsterhausen, 45147 Essen, Germany

About the sponsor

Clinical research in high-risk prostate cancer, very high-risk prostate cancer, and localized or locally advanced disease includes interest in PSMA PET, radioligand therapy, and preoperative treatment strategies for patients considered for radical prostatectomy or curative-intent radiotherapy.

  • PSMA PET imaging
  • Lu-PSMA radioligand therapy
  • Neoadjuvant prostate cancer treatment

The sponsor also studies biomarker-informed treatment selection in prostate cancer and imaging-guided approaches for defining local therapy.

About Specializations

Universitaetsklinikum Essen AöR runs clinical trials in conditions such as Non-small cell lung cancer, Prostate cancer, Colorectal cancer, Non-small cell lung cancer stage IIIB, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

10 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Universitaetsklinikum Essen AöR
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Universitaetsklinikum Essen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177Lu) Vipivotide Tetraxetan
  • Sponsor:Universitaetsklinikum Essen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide
  • Sponsor:Universitaetsklinikum Essen AöR

Gastric cancer+6

Not yet recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
  • Sponsor:Universitaetsklinikum Essen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Universitaetsklinikum Essen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Universitaetsklinikum Essen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Universitaetsklinikum Essen AöR
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Universitaetsklinikum Essen AöR
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Tacrolimus
  • Sponsor:Universitaetsklinikum Essen AöR

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.